Interviews with Icons: Abraham Morgentaler, MD, FACS, and Testosterone Therapy in Clinical Medicine
Neil H. Baum, MD, interviews Abraham Morgentaler, MD, FACS, on his clinical research treating men using testosterone therapy.
Read More
2022
How the Addition of Multiparametric MRI has Changed a Private Practice Setting in Prostate Screening
Richard G. Barr, MD, PhD, FACR, FSRU, describes how mpMRI has changed prostate cancer screening for a small radiology practice group.
Read More
The Manogram: Role of MRI in Prostate Cancer Screening
Peter A. Pinto, MD, discusses the utility of MRI in prostate cancer screening, including mpMRI and the more cost-effective bpMRI.
Read More
Risk-Adapted TURBT
In this 20-minute video, Seth P. Lerner, MD, Professor of Urology and Vice-chair for Faculty Affairs in the Scott Department of Urology, and Director of Urologic Oncology and the Multidisciplinary Bladder Cancer Program at Baylor University, discusses risk-adapted transurethral resection of bladder tumor (TURBT). He assesses TURBT’s role in staging and treatment and considers its use in bladder preservation.
Read More
IP1-Prostagram Screening Study: Comparing PSA, MRI and Ultrasound
Hashim Ahmed, MD, discusses the IP1-Prostagram Screening Study that looked at using MRI for screening of prostate cancer.
Read More